Literature DB >> 14688273

Phosphatidylinositol 3-kinase and mTOR signaling pathways regulate RNA polymerase I transcription in response to IGF-1 and nutrients.

Martyn J James1, Joost C B M Zomerdijk.   

Abstract

Regulation of ribosomal RNA gene transcription by RNA polymerase I (Pol I) is fundamental to ribosome biogenesis and therefore protein translation capacity and cell growth, yet little is known of the key signaling cascades involved. We show here that insulin-like growth factor-1 (IGF-1)-induced Pol I transcription in HEK293 cells is entirely dependent on phosphatidylinositol 3-kinase (PI3K) activity and, additionally, is modulated by the mammalian target of rapamycin (mTOR), which coordinates Pol I transcription with the availability of amino acids. The mitogen-activated protein kinase (MAPK) pathway is weakly stimulated by IGF-1 in these cells and partly contributes to Pol I transcription regulation. Activation of Pol I transcription by IGF-1 results from enhancement of the activity of the Pol I transcription machinery and increased occupancy by SL1 of the endogenous tandemly repeated ribosomal promoters in vivo. The inputs from PI3K, mTOR, and MAPK pathways converge to direct appropriate rRNA gene expression by Pol I in the nucleolus of mammalian cells in response to environmental cues, such as growth factors and nutrients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14688273     DOI: 10.1074/jbc.M307735200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  RNA polymerase 1-driven transcription as a mediator of BDNF-induced neurite outgrowth.

Authors:  Cynthia Gomes; Scott C Smith; Mark N Youssef; Jing-Juan Zheng; Theo Hagg; Michal Hetman
Journal:  J Biol Chem       Date:  2010-11-23       Impact factor: 5.157

Review 2.  Emerging roles of the neuronal nucleolus.

Authors:  Michal Hetman; Maciej Pietrzak
Journal:  Trends Neurosci       Date:  2012-02-02       Impact factor: 13.837

3.  A novel TBP-associated factor of SL1 functions in RNA polymerase I transcription.

Authors:  Julia J Gorski; Shalini Pathak; Kostya Panov; Taciana Kasciukovic; Tanya Panova; Jackie Russell; Joost C B M Zomerdijk
Journal:  EMBO J       Date:  2007-02-22       Impact factor: 11.598

4.  Akt activation enhances ribosomal RNA synthesis through casein kinase II and TIF-IA.

Authors:  Le Xuan Truong Nguyen; Beverly S Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

5.  Rapamycin inhibits liver growth during refeeding in rats via control of ribosomal protein translation but not cap-dependent translation initiation.

Authors:  Padmanabhan Anand; Philip A Gruppuso
Journal:  J Nutr       Date:  2006-01       Impact factor: 4.798

6.  Regulation of gene expression in hepatic cells by the mammalian Target of Rapamycin (mTOR).

Authors:  Rosa H Jimenez; Ju-Seog Lee; Mirko Francesconi; Gastone Castellani; Nicola Neretti; Jennifer A Sanders; John Sedivy; Philip A Gruppuso
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

7.  Effects of gene therapy on muscle 18S rRNA expression in mouse model of ALS.

Authors:  María Moreno-Igoa; Raquel Manzano; Sara Oliván; Ana C Calvo; Janne M Toivonen; Rosario Osta
Journal:  BMC Res Notes       Date:  2010-11-02

8.  TOR-dependent reduction in the expression level of Rrn3p lowers the activity of the yeast RNA Pol I machinery, but does not account for the strong inhibition of rRNA production.

Authors:  Anja Philippi; Robert Steinbauer; Alarich Reiter; Stephan Fath; Isabelle Leger-Silvestre; Philipp Milkereit; Joachim Griesenbeck; Herbert Tschochner
Journal:  Nucleic Acids Res       Date:  2010-04-25       Impact factor: 16.971

Review 9.  The nucleolus under stress.

Authors:  Séverine Boulon; Belinda J Westman; Saskia Hutten; François-Michel Boisvert; Angus I Lamond
Journal:  Mol Cell       Date:  2010-10-22       Impact factor: 17.970

10.  FACT facilitates chromatin transcription by RNA polymerases I and III.

Authors:  Joanna L Birch; Bertrand C-M Tan; Kostya I Panov; Tatiana B Panova; Jens S Andersen; Tom A Owen-Hughes; Jackie Russell; Sheng-Chung Lee; Joost C B M Zomerdijk
Journal:  EMBO J       Date:  2009-02-12       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.